Date: Mon, 27 Jan 2003 11:30:40 -2000 From: "Investment" <polltis@baysystems.com.pk> To: <achor@earthlink.net> Cc: <cvs-all@freebsd.org>, <jeffssweet@aol.com>, <sales@decoratorsbox.com>, <blc_cruz20@hotmail.com>, <sascha.uhl@tenovis.com>, <nezofolowo@vimoleri.org>, <dtol@desconnect.com>, <capt.fantastic@worldnet.att.net>, <lewro1@yahoo.com>, <s.g.trapp@worldnet.att.net>, <newsboys_17@yahoo.com.au> Subject: Performers1715 Message-ID: <0000105d747e$00002c2f$00001877@www.vrg.se>
next in thread | raw e-mail | index | archive | help
BUY NASDAQ: MSGL (OTC BB) – Medical Technology Sector; MRI Scanning Software Systems Groundbreaking Upgrade Allows 10X more Resolution, at 10% of the cost of a new machine; Proven existing market of $1.3B for this product. The product is patented, FDA approved and currently just beginning to be implemented at many major institutions. The software allows for MRI resolutions of up to 1.3 Tesla’s compared to existing clarity of 0.5 Tesla’s. Investors who are still making money in the stock market are those who know what stocks are in play or stocks about to be promoted/syndicated. By now you probably realize that stocks don’t just go up but are pushed up by brokerage firms that give companies exposure and analyst coverage – they promote them! To make money, an investor needs to buy at the beginning of the PUSH and sell within a 60-day period. We report on which stocks are being pushed and at what price levels to buy and sell at. Our current pick, OTCBB: MSGL is poised to move quickly with solid fundamentals, excellent news to be released continually over the next several weeks and a full-blown exposure campaign and promotion underway. Trading Symbol--------MSGL Exchange Listing------NASDAQ OTCBB Capital Structure-----Total Float/DTC 5.8m, of which 4.4 million are tightly held/friendly Recent High-----------$0.40 Recent Low------------$0.08 30-day Avg Volume-----40,000 30-day price target---$0.50 NASDAQ OTCBB: MSGL - Listed Medical Technology MRI Software Company MSGL – Developers of a Revolutionary MRI upgrade software package (currently being implemented in facilities across the U.S.) that produces images with up to 10X more clarity and resolution than standard MRI processing software at a fraction of the price. MSGL’s ground-breading SLICES software manipulates raw data matrices obtained through the MRI scanning process. Through the use of advanced calculations (MicroSignal's EXACT method), SLICES is able to produce images that boast up to 10 times more clarity and resolutions than standard MRI processing software. In addition to superior image quality, and because of the method of processing, SLICES™ is able to significantly reduce patient scan time and the need for patient call backs and rescanning. These factors also can contribute to a reduction in film consumption of up to 40%. At the end of 2002, there were approximately 10,500 MRI (magnetic resonance imaging) systems installed worldwide. While changes in medical reimbursement have slowed the sale of new MRI machines, and the ever-increasing demand for improved image quality and reduced patient scan time; thus there has been a tremendous need for products that can improve patient throughput and image quality. OTCBB: MSGL has solved this problem with its low cost software that upgrades existing installed MRI systems to the quality of a new machine at a savings of approximately $1.4 million per machine. The total estimated market for this system is in excess of $1.3B. NASDAQ OTCBB: MSGL is expected to capture approximately 40% of this market within 3 years, resulting in revenues of approximately $500 million, with a Net Margin of approximately 35%, or over $100 million in earnings. Other medical technology / software & system developers such as Baxter Medical NYSE: BAX – p/e of 20X; NASDAQ: NMMD, p/e of 31.4, NASDAQ: NMDC, p/e of 20X; an average of 24X current EPS, and 20X 1 yr forward expected earnings. In comparison to these valuations, NASDAQ OTCBB: MSGL, with its proven market for its product, sales on the books for the current quarter and a successful product launch already would be more fairly valued at 25X–to-30X forward earnings or $2.00 –to- $3.00 per share currently. For more information, see the company’s website: microsignalcorp.com/index2.htm ******************************************************* ***********************Disclaimer******************** Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects", "estimates," "believes," "understands" "will," "anticipates," or that by statements indicating certain actions "may," "could," or "might" occur. All information provided within this email pertaining to investing, stocks, securities must be understood as information provided and not investment advice. Emerging Equity Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice. In compliance with the Securities Act of 1933, Section 17(b), Emerging Stock Alert discloses the receipt of 50,000 unrestricted shares of MSGL from a third party for the publication of this report. Be aware of an inherent conflict of interest resulting from such compensation due to our intent to profit from the liquidation of these shares. Shares may be sold at any time, even after positive statements have been made regarding the above company. All factual information in this report was gathered from public sources, including but not limited to SEC filings, Company Press Releases, and Market Guide. Emerging Equity Alert believes this information to be reliable but can make no guarantee as to its accuracy or completeness. Use of the material within this email constitutes your acceptance of these terms. ****** Advertising Disclaimer ****** We are an internet advertising company and have received a monetary payment for this mailing service We hold no stocks and have no personal interest in this company whatsoever. We are simply being paid to perform a service. ****** Removal Instructions ****** This message has been sent to you in compliance with our strict anti-abuse regulations. We will continue to bring you valuable offers on the products and services that interest you most. If you do not wish to receive further mailings, please click below. We respect all removal requests. To be removed immediately from our mailing lists just click on the link below: MailTo:cal6517@excite.com Be sure that "Please Remove" is in the subject line of the email prior to sending it. This message is a paid advertisement. To Unsubscribe: send mail to majordomo@FreeBSD.org with "unsubscribe cvs-all" in the body of the message
Want to link to this message? Use this URL: <https://mail-archive.FreeBSD.org/cgi/mid.cgi?0000105d747e$00002c2f$00001877>